Everest Medicines Announces New Drug Application Acceptance by Singapore HSA for Nefecon for the Treatment of Primary IgA Nephropathy ...Middle East

Nefecon NDA is currently under Priority Review in China and expected to receive approval in 2H 2023 SHANGHAI, April 5, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and...

Hence then, the article about everest medicines announces new drug application acceptance by singapore hsa for nefecon for the treatment of primary iga nephropathy was published today ( Thursday 06/04/2023 - 02:32 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Everest Medicines Announces New Drug Application Acceptance by Singapore HSA for Nefecon for the Treatment of Primary IgA Nephropathy )

Also on site :

• Aurora man arrested on suspicion of starting massive Leetsdale Drive fire
• Indiana Toll Road shut down after pileup crash involving around 29 vehicles
• Taylor Swift Supports Brad Paisley's Nashville Charity With a Generous Gift: 'Never Forgets Her Roots'